» Articles » PMID: 17618441

The 2007 WHO Classification of Tumours of the Central Nervous System

Overview
Specialty Neurology
Date 2007 Jul 10
PMID 17618441
Citations 5064
Authors
Affiliations
Soon will be listed here.
Abstract

The fourth edition of the World Health Organization (WHO) classification of tumours of the central nervous system, published in 2007, lists several new entities, including angiocentric glioma, papillary glioneuronal tumour, rosette-forming glioneuronal tumour of the fourth ventricle, papillary tumour of the pineal region, pituicytoma and spindle cell oncocytoma of the adenohypophysis. Histological variants were added if there was evidence of a different age distribution, location, genetic profile or clinical behaviour; these included pilomyxoid astrocytoma, anaplastic medulloblastoma and medulloblastoma with extensive nodularity. The WHO grading scheme and the sections on genetic profiles were updated and the rhabdoid tumour predisposition syndrome was added to the list of familial tumour syndromes typically involving the nervous system. As in the previous, 2000 edition of the WHO 'Blue Book', the classification is accompanied by a concise commentary on clinico-pathological characteristics of each tumour type. The 2007 WHO classification is based on the consensus of an international Working Group of 25 pathologists and geneticists, as well as contributions from more than 70 international experts overall, and is presented as the standard for the definition of brain tumours to the clinical oncology and cancer research communities world-wide.

Citing Articles

Nonenhancing Prepontine Chordoma with Diffusion Restriction Mimicking an Epidermoid Cyst.

Charan B, Agarwal S, Singh E, Jain S, Sumanta Das , Garg A Asian J Neurosurg. 2025; 20(1):138-142.

PMID: 40041598 PMC: 11875700. DOI: 10.1055/s-0044-1791581.


Toxicities Associated with Adjuvant Radiation Therapy in Atypical Meningioma.

Lee G, Aitelli A, Niemierko A, Lamba N, Kim D, Curry W Adv Radiat Oncol. 2025; 10(3):101726.

PMID: 40034477 PMC: 11872651. DOI: 10.1016/j.adro.2025.101726.


How useful is contrast-enhanced MRI in the long-term surveillance of glioma? A multicentre retrospective longitudinal cohort study.

Cakmak M, Mohammadian S, Keil V, Schouten J, de Witt Hamer P, van der Vaart T Eur Radiol. 2025; .

PMID: 40016316 DOI: 10.1007/s00330-024-11333-y.


Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies.

Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A Mol Cancer. 2025; 24(1):58.

PMID: 40011944 PMC: 11863469. DOI: 10.1186/s12943-025-02267-0.


AAV-based vectors for human diseases modeling in laboratory animals.

Aliev T, Yudkin D Front Med (Lausanne). 2025; 11:1499605.

PMID: 40007819 PMC: 11859266. DOI: 10.3389/fmed.2024.1499605.


References
1.
Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre P, Franceschi S . Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol. 2006; 65(9):846-54. DOI: 10.1097/01.jnen.0000235118.75182.94. View

2.
Preusser M, Dietrich W, Czech T, Prayer D, Budka H, Hainfellner J . Rosette-forming glioneuronal tumor of the fourth ventricle. Acta Neuropathol. 2003; 106(5):506-8. DOI: 10.1007/s00401-003-0758-2. View

3.
Jouvet A, Fauchon F, Liberski P, Saint-Pierre G, Didier-Bazes M, Heitzmann A . Papillary tumor of the pineal region. Am J Surg Pathol. 2003; 27(4):505-12. DOI: 10.1097/00000478-200304000-00011. View

4.
Kim D, Suh Y . Pseudopapillary neurocytoma of temporal lobe with glial differentiation. Acta Neuropathol. 1997; 94(2):187-91. DOI: 10.1007/s004010050692. View

5.
Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109. PMC: 1929165. DOI: 10.1007/s00401-007-0243-4. View